Li N. Komatsu

Array ( [id] => 13139801 [patent_doc_number] => 10087221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-02 [patent_title] => Synthesis of hydantoin containing peptide products [patent_app_type] => utility [patent_app_number] => 14/778496 [patent_app_country] => US [patent_app_date] => 2014-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4124 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13139801 [patent_doc_number] => 10087221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-02 [patent_title] => Synthesis of hydantoin containing peptide products [patent_app_type] => utility [patent_app_number] => 14/778496 [patent_app_country] => US [patent_app_date] => 2014-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4124 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11779120 [patent_doc_number] => 09388215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Compositions and methods of using islet neogenesis peptides and analogs thereof' [patent_app_type] => utility [patent_app_number] => 14/417110 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 25142 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735795 [patent_doc_number] => 20140271507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Skin Compositions and Uses' [patent_app_type] => utility [patent_app_number] => 14/210328 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28205 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933100 [patent_doc_number] => 20140336121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'FACTOR H FOR TREATMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 14/210091 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24729 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10566316 [patent_doc_number] => 09289466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Modified binding proteins inhibiting the VEGF-A receptor interaction' [patent_app_type] => utility [patent_app_number] => 14/206054 [patent_app_country] => US [patent_app_date] => 2014-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13498 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15052345 [patent_doc_number] => 10456448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => PTD-SMAD7 therapeutics [patent_app_type] => utility [patent_app_number] => 14/773167 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 94 [patent_no_of_words] => 34688 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14390825 [patent_doc_number] => 10308682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Inhibition of tumor growth with aggregates of small molecules [patent_app_type] => utility [patent_app_number] => 14/773690 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 82 [patent_no_of_words] => 10456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11249222 [patent_doc_number] => 09474706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Composition for maintaining effect of filler' [patent_app_type] => utility [patent_app_number] => 14/771372 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4531 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414246 [patent_doc_number] => 20150299256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'ANTIBIOTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/188913 [patent_app_country] => US [patent_app_date] => 2014-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24703 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9546715 [patent_doc_number] => 20140171364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'STABLE GLUCAGON FORMULATIONS FOR THE TREATMENT OF HYPOGLYCEMIA' [patent_app_type] => utility [patent_app_number] => 14/186367 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8371 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968126 [patent_doc_number] => 20140371159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'IN VITRO METHOD FOR MODIFYING THE DEPLETION PROFILE OF TREG CELLS PRESENT IN A TOTAL SPLENOCYTE POPULATION OF A BIOLOGICAL SAMPLE BY MEANS OF THE ISOLATION, CULTURING AND EXPOSURE THEREOF TO AN ATP AND POLYMIXIN B MEDIUM' [patent_app_type] => utility [patent_app_number] => 14/181810 [patent_app_country] => US [patent_app_date] => 2014-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4554 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14181810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656166 [patent_doc_number] => 20160002310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'MODIFIED INGAP PEPTIDES FOR TREATING DIABETES' [patent_app_type] => utility [patent_app_number] => 14/768452 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 21619 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10686133 [patent_doc_number] => 20160032278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'SCAFFOLD PROTEINS DERIVED FROM PLANT CYSTATINS' [patent_app_type] => utility [patent_app_number] => 14/768032 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26603 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10483280 [patent_doc_number] => 20150368300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'COMPOSITIONS AND METHODS RELATING TO HINDERING DOT1L RECRUITMENT BY MLL-FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/763596 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23241 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14763596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11736062 [patent_doc_number] => 09700633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof' [patent_app_type] => utility [patent_app_number] => 14/764166 [patent_app_country] => US [patent_app_date] => 2014-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 22268 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561277 [patent_doc_number] => 20140178990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'CELL PROLIFERATION-PROMOTING PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/163371 [patent_app_country] => US [patent_app_date] => 2014-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8851 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14163371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628916 [patent_doc_number] => 09347062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Interfering RNA delivery system and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/156227 [patent_app_country] => US [patent_app_date] => 2014-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7169 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642209 [patent_doc_number] => 09663565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Insulinotropic peptide derivative with modified N-terminal charge' [patent_app_type] => utility [patent_app_number] => 14/758842 [patent_app_country] => US [patent_app_date] => 2014-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7259 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10192985 [patent_doc_number] => 09221880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Antibacterial agents: salinamide derivatives' [patent_app_type] => utility [patent_app_number] => 14/104914 [patent_app_country] => US [patent_app_date] => 2013-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12117 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14104914 [rel_patent_id] =>[rel_patent_doc_number] =>)